BNT-113 is under clinical development by BioNTech and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...
The Bahamas National Trust has announced the appointment of new officers and members of the BNT Council, elected at its Annual General Meeting (AGM) in October. Joanne Smith has been elected as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback